2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Singularity Future Technology Ltd. sold common stock and pre-funded warrants in two registered direct offerings, dated August 18 and August 20, 2026, for gross proceeds of about $1.8 million and $5.0 million before fees and expenses. The company will use the proceeds for working capital and, in the second offering, its planned data center business, and the new shares and warrants add to the share count shareholders own.
First offering, closed August 19, 2026: 340,000 common shares at $3.00 each plus pre-funded warrants for 260,000 shares, for about $1.8 million gross.
Second offering, closed August 21, 2026: 451,250 common shares at $3.20 each plus pre-funded warrants for up to 1,111,250 shares, for about $5.0 million gross.
Placement agent Univest Securities LLC receives a fee of 7% of gross proceeds, and the company agreed not to issue more shares or file new registration statements for 30 days after the closings.
The Purchaser's right to buy up to an additional 100% of its first-offering shares, which ran through September 18, 2026, was terminated.
Ensysce Biosciences said its first tranche of a Series C Preferred Stock financing, totaling roughly $43 million, closed on August 7, 2026, raising more than $21 million in gross proceeds. The company believes this restores compliance with Nasdaq's minimum stockholders' equity requirement and that it qualifies for a second 180-day grace period to regain compliance with the $1.00 bid price rule.
First tranche closed August 7, 2026, raising more than $21 million gross; total financing is about $43 million for 120,260 Series C Preferred shares
Second tranche depends on a clinical trial milestone that has not yet occurred
Company believes stockholders' equity is at least $2.5 million, meeting the Nasdaq Rule 5550(b)(1) requirement, pending Nasdaq confirmation
Second 180-day bid price grace period was requested from Nasdaq on August 24, 2026; Nasdaq response is pending
Jupiter Neurosciences sold 307,692 shares at $6.50 each in a registered direct offering that closed August 24, 2026, for gross proceeds of about $2.0 million before fees and expenses. The company believes the sale brings its stockholders' equity above the $2.5 million Nasdaq continued-listing requirement, but it is still waiting for Nasdaq's formal confirmation, and its shares may face delisting if compliance is not shown at its next periodic report.
Shares issued: 307,692 common shares at $6.50 each, under an agreement dated August 21, 2026
Gross proceeds: approximately $2.0 million before placement agent fees and offering expenses, closed August 24, 2026
Nasdaq stockholders' equity requirement: $2.5 million; company awaiting formal determination of compliance
Delisting risk remains if compliance is not evidenced at the next periodic report
Backblaze issued $201.25 million of 0.00% convertible senior notes maturing August 15, 2031, including the full $26.25 million option exercised by the initial purchasers. The notes can convert into cash, Class A common stock, or both at the company's election, at about $21.94 per share, a 30% premium to the $16.88 closing price on August 19, 2026. The new debt could dilute existing shareholders if converted, though the company also bought capped call transactions, at a cost of about $17.5 million, that are intended to reduce that dilution.
Notes totaling $201.25 million were issued August 24, 2026, including the $26.25 million option exercised in full.
Initial conversion price is about $21.94 per share, a 30% premium to the $16.88 closing price on August 19, 2026.
Capped call transactions cost about $17.5 million, with a cap price of $33.76 per share.
The revolving credit facility rose from $20 million to $50 million and its maturity was extended from June 4, 2028 to April 30, 2030.
On August 24, 2026, Charter Communications Operating and its co-issuer completed the final settlement of their exchange offers for senior secured notes, issuing additional 2038 and 2041 notes in exchange for older notes. The exchanges swap existing debt for new 7.087% and 7.337% senior secured notes, so the filing shows a refinancing of existing obligations rather than new borrowing in cash.
Final Settlement Date was August 24, 2026, after the offers expired at 5:00 p.m. New York City time on August 20, 2026.
Issued $55,928,000 in additional 7.087% Senior Secured Notes due 2038 in exchange for $84,390,000 of Pool 1 notes.
Issued $35,750,000 in additional 7.337% Senior Secured Notes due 2041 in exchange for $60,634,000 of Pool 2 notes.
New notes are senior secured and mature in 2038 and 2041, with interest payable each March 1 and September 1, starting March 1, 2027.
On August 18, 2026, Air Industries Group signed a Twelfth Amendment to its Loan and Security Agreement with Webster Bank, extending the maturity of its revolving credit and term loans to November 30, 2026. Concurrently, the holders of its subordinated notes, Michael Taglich and Robert Taglich, agreed to extend those notes' maturity to December 1, 2026. The filing does not state loan amounts or other terms, so the change mainly moves the dates by which the company must repay this debt.
Twelfth Amendment to Loan and Security Agreement with Webster Bank dated August 18, 2026
Revolving credit and term loan maturity extended to November 30, 2026
Subordinated notes held by Michael Taglich and Robert Taglich extended to December 1, 2026
Filing dated August 24, 2026 and signed by Acting Chief Executive Officer Scott Glassman; loan amounts not disclosed in the filing
Tyson Foods completed a public offering of $1 billion in senior unsecured notes on August 24, 2026, split evenly between $500 million of 5.100% notes due 2031 and $500 million of 5.600% notes due 2037. The filing describes the terms and covenants of the notes, which add to the company's debt obligations and carry fixed interest payments through maturity.
$500 million of 5.100% Senior Notes mature August 24, 2031; interest paid semiannually from February 24, 2027
$500 million of 5.600% Senior Notes mature January 24, 2037; interest paid semiannually from January 24, 2027
Notes are general senior unsecured obligations, ranking equally with the company's other senior unsecured debt
Indenture limits secured debt, sale and lease-back transactions, and mergers or asset transfers, subject to exceptions
On August 24, 2026, Valvoline closed a $600 million offering of 6.125% senior notes maturing August 15, 2034, and plans to use the proceeds mainly to repay its senior secured term loan A in full and partly repay term loan B. The same day, it amended its credit agreement to raise the revolving credit facility from $475 million to $600 million, extend its maturity five years from August 24, 2026, and raise the maximum consolidated net leverage covenant from 4.50:1.00 to 5.00:1.00, stepping down later. The filing shows more borrowing capacity and covenant room for Valvoline, alongside new long-term debt.
$600 million of 6.125% senior notes due August 15, 2034, closed August 24, 2026; trustee is U.S. Bank Trust Company, National Association
Net proceeds intended to repay term loan A in full, partly repay term loan B, and pay fees and expenses
Revolving credit facility increased from $475 million to $600 million, with pricing reduced and maturity extended
Maximum consolidated net leverage covenant raised from 4.50:1.00 to 5.00:1.00, stepping down to 4.75:1.00 and 4.50:1.00 in years three and four
On August 21, 2026, Skye Bioscience entered a Securities Purchase Agreement with an affiliate of Redmile Group under which the company can sell up to $22,000,000 of its common stock over three years, subject to conditions. The deal is tied to the proposed acquisition of Redx Pharma Limited and a related private placement, and the share sales would add to the number of shares outstanding.
Equity line of up to $22,000,000, reduced by any amount the funded PIPE exceeds $103,000,000; no shares are sold if the funded PIPE amount reaches $125,000,000 or more
Monthly sales capped at $2,000,000 of shares, priced at the lesser of the PIPE price and market price, with a floor 10% below the PIPE price
Warrant issued at closing to purchase shares equal to $5,000,000 divided by the PIPE price, exercisable from January 1, 2027 to January 1, 2030
Share issuances capped at 19.99% of outstanding common stock absent stockholder approval; company must file a resale registration statement within 10 business days of the closing date
At its recessed annual meeting on August 21, 2026, New Concept Energy stockholders approved issuing 2,000,000 new common shares to Realty Advisors, Inc. (RAI) for $1.00 per share in cash, or $2,000,000 in total. The issuance will proceed only after the NYSE American approves the additional listing application, and the filing states that it will cause a change in control, with RAI owning about 33.65% of outstanding shares afterward.
Stockholders approved the issuance with 1,872,051 votes for, 128,492 against and 120 abstentions.
RAI will pay $1.00 per share, $2,000,000 in total, from its working capital once the NYSE American approves the listing.
After the issuance RAI would hold 2,400,000 of 7,131,935 outstanding shares, about 33.65%, versus 400,000 shares (7.79%) it holds now.
MPLX LP filed exhibits under its Form S-3 shelf registration, including an underwriting agreement dated August 10, 2026 with five underwriters and three supplemental indentures dated August 24, 2026 with The Bank of New York Mellon Trust Company as trustee. The filing indicates a debt offering under the shelf, but it does not state the amount, pricing, or coupon terms. For shareholders, the filing is administrative and does not disclose a change in earnings or guidance.
Underwriting agreement dated August 10, 2026 with TD Securities, Goldman Sachs, J.P. Morgan, SMBC Nikko and Wells Fargo as representatives
Thirty-Eighth, Thirty-Ninth and Fortieth Supplemental Indentures dated August 24, 2026 with The Bank of New York Mellon Trust Company, N.A.
Exhibits filed under Registration Statement on Form S-3 (No. 333-295600), including a Jones Day legal opinion
Expion Energy closed a $9.0 million private placement of 8% convertible debentures, with about $8.2 million in expected net proceeds, and acquired oil and gas assets in Eastern Louisiana for an adjusted cash price of $3,425,000. Kevin Sellers replaced Joseph Hammer as chief executive effective August 24, 2026, and the lead investor is affiliated with Hammer, who remains interim chairman. The financing is convertible into preferred stock and warrants, which could dilute shareholders, and the company is shifting into a new business line.
$9.0 million 8% convertible debentures due August 21, 2029, with net proceeds of about $8.2 million; conversion into Series A-1 preferred requires shareholder approval, with an initial conversion price of $4.25 per share.
Warrants to purchase up to 2,117,219 common shares; investors may buy up to $91.0 million of additional convertible preferred stock, subject to shareholder approval.
Acquired Eastern Louisiana oil and gas assets for an adjusted cash price of $3,425,000; the exploration agreement commits up to $4,000,000 to leasing and calls for a new lateral wellbore by February 15, 2027.
Kevin Sellers named CEO and board member effective August 24, 2026; lead purchaser Five Narrow Lane LP is affiliated with Joseph Hammer, who stepped down as CEO and remains interim chairman.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.